SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

Knight Therapeutics forecasts FY revenue of C$560–570 million

The outlook is above the supplied IBES estimate of C$552.4 million.

Related stories